Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.96 USD | +4.59% | +6.47% | -29.52% |
05-10 | First Wave BioPharma, Inc. announced a financing transaction | CI |
03-29 | First Wave BioPharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.52% | 5.73M | |
+33.37% | 49.46B | |
+1.55% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.57% | 26.61B | |
-21.00% | 18.64B | |
+7.36% | 13.16B | |
+28.30% | 12.55B | |
+23.80% | 12.1B |
- Stock Market
- Equities
- FWBI Stock
- News First Wave BioPharma, Inc.
- AzurRx BioPharma : HC Wainwright Adjusts Price Target on AzurRx BioPharma to $2.50 From $3.50, Maintains Buy Rating